Home
Currax Pharmaceuticals

Currax Pharmaceuticals Market Share Analysis for August 2026

Explore our open positions and become part of our journey

Industry: N/A

Domaincurraxpharma.com

Year Founded2019

Employees51 - 200

Annual Revenue--

Currax Pharmaceuticals

Currax Pharmaceuticals (including company regionals)

curraxpharma.com

See more website traffic and engagement information

Total visits to Currax Pharmaceuticals's top domains

Understand Currax Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

curraxpharma.com8.4K

See more with Sales Intelligence

Avg. visit duration in Currax Pharmaceuticals's top domains

Analyze Currax Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

curraxpharma.com00:00:11

See more with Sales Intelligence

Avg. pageviews on Currax Pharmaceuticals's top domains

See how Currax Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

curraxpharma.com1.43

See more with Sales Intelligence

Currax Pharmaceuticals top competitors by domain

Top similar sites in August 2026, ranked by their affinity

cardiosmart.orgCompany NameCardioSmartEmployees51 - 200HQUnited States, District of Columbia, Washington, D.C.Annual revenue$2M - $5MTotal visits78.7KHealth > Health Conditions and Concerns

Top technologies used by Currax Pharmaceuticals

These are the website technologies, by industry, used by Currax Pharmaceuticals top domains

Live Chat (7)

Tawk To

Payment & Currencies (5)

PayPal

Widget (5)

Twemoji

Conversion & Analytics (4)

Google Analytics

More Technologies

12

See all

News & Signals from Currax Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCurraxpharma went public on Aug 26th '25.Curanex conducted its Initial Public Offering ("IPO") on August 26, 2025, selling 3.75 million shares at $4.00 per share for gross proceeds of $15 million.

NewsCurraxpharma launched CurAccess Program on Oct 22nd '20.In support of this mission, Currax launched the CurAccess(TM) Program more than five years ago.

NewsCurraxpharma identified as competitor of Novo Nordisk A/S.Still, he stresses that Currax isn't competing directly with GLP-1 manufacturing giants Novo Nordisk and Eli Lilly, nor does it plan to.